Fundz

Viyash Scientific acquires BioForLife Italia for ₹188 crore

PRIVATEOct 06, 2026

Acquiring Company

Viyash Scientific

Acquired Company

BioForLife Italia S.r.l

HyderabadMilanBiotechnologyHealth Care

Description

Viyash Scientific Limited has acquired 100% shareholding of BioForLife Italia S.r.l for approximately ₹188 crore. The transaction was completed on October 1, 2026, following compliance with Italian FDI regulations. This acquisition enhances Viyash's portfolio in the veterinary sector, expanding its market presence in Europe.

Quick answer

Viyash Scientific is acquiring BioForLife Italia S.r.l for $20 million, announced October 6, 2026. Viyash Scientific is based in Hyderabad, Telangana, India.

How much did Viyash Scientific pay for BioForLife Italia S.r.l?
The reported deal value is $20 million.
What does Viyash Scientific do?
Viyash Scientific is an animal health and pharmaceutical company primarily focused on the production and distribution of formulations and active pharmaceutical ingredients (APIs).
Where are Viyash Scientific and BioForLife Italia S.r.l based?
Viyash Scientific is based in Hyderabad, Telangana, India. BioForLife Italia S.r.l is based in Milan, Lombardy, Italy.
Who are the decision-makers at Viyash Scientific?
Fundz holds 2 contacts at Viyash Scientific. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Viyash Scientific, and when

When Viyash Scientific changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Viyash Scientific raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Viyash Scientific, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Viyash Scientific. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Viyash Scientific

Location

Hyderabad, Telangana, India

About

Viyash Scientific is an animal health and pharmaceutical company primarily focused on the production and distribution of formulations and active pharmaceutical ingredients (APIs). The company has been experiencing significant growth and profitability in recent quarters. They aim to expand their presence in international markets, particularly in Europe. Viyash is recognized for its innovative solutions in the animal health sector.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Viyash Scientific makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Srinivas
Senior decision-maker at this company
••••••••@••••••••

See Srinivas's verified email →

Ramakant
Senior decision-maker at this company
••••••••@••••••••

See Ramakant's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Viyash Scientific's next move

Learn about Strategic plan

Frequently asked

Who acquired BioForLife Italia S.r.l?

BioForLife Italia S.r.l was acquired by Viyash Scientific, based in Hyderabad. The deal was reported on October 6, 2026. Viyash Scientific is an animal health and pharmaceutical company primarily focused on the production and distribution of formulations and active pharmaceutical ingredients (APIs). Viyash Scientific is privately held.

When did Viyash Scientific acquire BioForLife Italia S.r.l?

Viyash Scientific's acquisition of BioForLife Italia S.r.l was reported on October 6, 2026. Viyash Scientific Limited has acquired 100% shareholding of BioForLife Italia S.r.l for approximately ₹188 crore. The transaction was completed on October 1, 2026, following compliance with Italian FDI regulations. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does BioForLife Italia S.r.l do?

BioForLife Italia S.r.l. is a company engaged in the biotechnology sector. It focuses on developing life-enhancing biological products. The company aims to support health industries with innovative biotechnological solutions. It is privately held, operating in Biotechnology, and is based in Milan.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.